Jump to ContentJump to Main Navigation

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Tate, Jillian R. / Tsongalis, Gregory J.

12 Issues per year


IMPACT FACTOR 2014: 2.707
Rank 6 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR): 0.860
Source Normalized Impact per Paper (SNIP): 1.046

VolumeIssuePage

Issues

Comparison of Plasma Cardiac Troponins T and I in Chronically Hemodialyzed Patients in Relation to Cardiac Status and Age

Jean-Paul Chapelle / Bernard Dubois / Christophe Bovy / Marie-Claire Aldenhoff / Jacques Gielen / Georges Rorive

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 40, Issue 3, Pages 240–245, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2002.039, June 2005

Publication History

Published Online:
2005-06-01

Abstract

Cardiac troponins (cTnT and cTnI) are useful tools for risk stratification in patients with unstable angina. However, their value in patients with renal failure has been questioned.

In this study, we determined cTnT and cTnI at 3-month intervals during 9 months in 97 chronic renal failure (CRF) patients treated with hemodialysis. cTnT was measured using a third generation immunoassay and cTnI by fluorimetric immunoassay with a detection limit similar to that of cTnT (0.01 μg/l).

In the renal patients without coronary heart disease (CHD(−) group), cTnT was more frequently elevated above cut-off for acute myocardial infarction (AMI) (up to 21.6%) than cTnI (no patient). In the absence of CHD, cTnT levels were positively correlated to age, and more than half of the CHD(−) patients aged over 60 years had cTnT levels above the upper reference limit (URL) of 0.04 μg/l (0.059±0.042 μg/l). cTnI increased with age in parallel to cTnT but mean levels did not exceed the URL of 0.08 μg/l in the CHD(−) patients aged over 60 years (0.036±0.031 μg/l). In the patients with documented cardiac events (CHD(+)) we found higher troponin levels than in the CHD(−) patients of the corresponding age, but for cTnI the differences between CHD(+) and CHD(−) patients were significant in the patients aged ≤60 years only (0.049±0.054 vs.0.019±0.018 μg/l, p<0.05). For cTnT, the differences between patients with and without coronary events also tended to be less important in the eldest patients. There was a significant correlation between cTnI and cTnT levels in the CHD(−) and in the CHD(+) groups.

Changes in the plasma levels of cardiac troponins are common in hemodialysis patients in the absence of CHD, and advanced age appears to amplify these changes. The reason could be that most hemodialysis patients with advanced age have subclinical lesions and demonstrate release characteristics of troponins that compare to those in patients with symptomatic coronary events. Therefore, it will be important to analyze troponin elevations above the URL or above the cut-off concentration for AMI in asymptomatic renal patients in relation to prognosis.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Carlos Lafuente Gormaz, Ignacio Terrancle de Juan, and Luis Broseta Viana
Medicina Clínica, 2003, Volume 120, Number 10, Page 389
[2]
Amparo Galán, Antonio Curós, and Augusto Corominas
Medicina Clínica, 2004, Volume 123, Number 14, Page 551
[3]
C. Le Goff, C. Bovy, M.-C. Aldenhoff, J.-M. Krzesinski, and J.-P. Chapelle
Immuno-analyse & Biologie Spécialisée, 2007, Volume 22, Number 6, Page 377
[4]
A Lavoinne and B Cauliez
La Revue de Médecine Interne, 2004, Volume 25, Number 2, Page 115
[5]
Matthew A. Roberts, David L. Hare, Sujiva Ratnaike, and Francesco L. Ierino
American Journal of Kidney Diseases, 2006, Volume 48, Number 3, Page 341
[6]
Eberhard Gurr and Knut Leitz
Clinical Chemistry and Laboratory Medicine, 2004, Volume 42, Number 9
[7]
MATTHEW A ROBERTS, ADAM J HEDLEY, and FRANCESCO L IERINO
Nephrology, 2011, Volume 16, Number 3, Page 251
[8]
Eric H.Y. Ie, Peter J. Klootwijk, Willem Weimar, and Robert Zietse
Nephron Clinical Practice, 2004, Volume 98, Number 3, Page c87
[9]
JANAK R DE ZOYSA
Nephrology, 2004, Volume 9, Number 2, Page 83

Comments (0)

Please log in or register to comment.